Rafutrombopag (tautomerism), CAS [[2114365-78-3]]

Produktübersicht

• Artikelname: Rafutrombopag (tautomerism), CAS [[2114365-78-3]]
• Artikelnummer: MCE-HY-122620
• Hersteller Artikelnummer: HY-122620
• Alternativnummer: MCE-HY-122620-5MG,MCE-HY-122620-25MG,MCE-HY-122620-50MG,MCE-HY-122620-1MG,MCE-HY-122620-10MG,MCE-HY-122620-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Hetrombopag (tautomerism), SHR-8735 (tautomerism)

Produktbeschreibung

Rafutrombopag (tautomerism) is a potent thrombopoietin receptor agonist. Rafutrombopag (tautomerism) is efficacious and well tolerated with a manageable safety profile. Rafutrombopag (tautomerism) has the potential for the research of immune thrombocytop

Produkteigenschaften

• Molekulargewicht: 458.47
• Reinheit: 98.16
• CAS Nummer: [2114365-78-3]
• Formel: C25H22N4O5
• Target-Kategorie: Thrombopoietin Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound